Healthcare -
Biotechnology - NASDAQ - US
$ 9.36
-1.06 %
$ 496 M
Market Cap
-4.5
P/E
STOK - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities STOK - Stoke Therapeutics, Inc.
106 M
LAST VALUE
84.02%
2 YEAR CAGR
159.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR